A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

Weight-loss jabs could prevent and treat addiction to alcohol, cigarettes and drugs, according to a large study. Experts ...

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Use of some GLP-1 drugs like Wegovy, Ozempic and Victoza could help curb drinking in those struggling with alcohol use disorder, a new study by European researchers published Wednesday suggests, the ...

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...

Researchers identify the anterior insula as the brain region responsible for biasing decisions toward alcohol over social rewards in addiction.

People taking GLP-1 drugs often talk about “food noise” vanishing: the constant mental chatter about food that dominated thei ...

Semaglutide, the active ingredient behind blockbuster weight-loss drugs like Wegovy, is now at the center of a growing body of evidence suggesting it can sharply reduce alcohol consumption in people ...

A diabetes and obesity medication shows potential to reduce alcohol cravings and relapse in early animal studies.

WALKING away from any kind of addiction is not easy as it requires the concerned person to fully commit to the quitting ...

New York lawmakers introduce bills to tax alcohol and redirect opioid tax revenue to fund substance use disorder treatment as ...